1-2 of 2
Jesper Johannesen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial

Ida M. Mynarek, Lars Krogvold, Freja B. Mørk, Trine W.H. Lawaetz, Trine Roald, Morten W. Fagerland, Nina Lindblom, Jacob Westman, Peter Barker, Heikki Hyöty, Johnny Ludvigsson, Kristian F. Hanssen, Jesper Johannesen, Knut Dahl-Jørgensen
Journal: Diabetes Care
Diabetes Care 2025;48(3):481–488
https://doi.org/10.2337/dc24-2121
Published: 13 January 2025
View articletitled, Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial
Open the PDF for Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial in another window
Journal Articles

Residual β-Cell Function 3–6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents

Jesper S. Sørensen, MD, Jesper Johannesen, MD, Flemming Pociot, MD, Kurt Kristensen, MD, Jane Thomsen, BN, N. Thomas Hertel, MD, Per Kjaersgaard, MD, Caroline Brorsson, MD, Niels H. Birkebaek, MD, the Danish Society for Diabetes in Childhood and Adolescence
Journal: Diabetes Care
Diabetes Care 2013;36(11):3454–3459
https://doi.org/10.2337/dc13-0418
Published: 15 October 2013
View articletitled, Residual β-Cell Function 3–6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents
Open the PDF for Residual β-Cell Function 3–6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents in another window